Results 171 to 180 of about 50,064 (212)

Autoallergy and what the Allergist Needs to know. [PDF]

Curr Allergy Asthma Rep
Steinert C, Pashuk M, Kolkhir P, Kocatürk E, Xiang YK.   +4 more
europepmc   +1 more source

The Spliceosomal Peptidyl Prolyl Isomerase Like 1 Interacts with the Low-Complexity Domain of the RNA Binding Protein EWS Modulating Its Phase Separation Behavior. [PDF]

Biochemistry
Parra GL, Sohn EJ, Xu X, Libich DS.
europepmc   +1 more source

Cyclophilin J limits linear ubiquitin signaling and controls colorectal cancer progression. [PDF]

J Biol Chem
Sheng C, Yao C, Wang J, Mao Y, Fu L, Chen S.   +5 more
europepmc   +1 more source

Impact of Apolipoprotein E4 on Blood-Brain Barrier Integrity in Target Replacement Murine Models: A Systematic Review and Meta-Analysis

Laing K, Fialova N, Wardlaw J, Montagne A.   +3 more
europepmc   +1 more source

A cyclophilin-dependent mitochondrial pore

openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Oligopeptide cyclophilin inhibitors: A reassessment

European Journal of Medicinal Chemistry, 2011
Potent cyclophilin A (CypA) inhibitors such as non-immunosuppressive cyclosporin A (CsA) derivatives have been already used in clinical trials in patients with viral infections. CypA is a peptidyl prolyl cis/trans isomerase (PPIase) that catalyzes slow prolyl bond cis/trans interconversions of the backbone of substrate peptides and proteins.
Michael, Schumann, Günther, Jahreis, Viktoria, Kahlert, Christian, Lücke, Gunter, Fischer   +4 more
openaire   +2 more sources

Cyclophilin D as a Drug Target

Current Medicinal Chemistry, 2003
The mitochondrial permeability transition (MPT) plays an important role in damage-induced cell death, and agents inhibiting the MPT may have a therapeutic potential for treating human conditions such as ischemia/reperfusion injury, trauma, and neurodegenerative diseases.
Peter C, Waldmeier, Kaspar, Zimmermann, Ting, Qian, Marina, Tintelnot-Blomley, John J, Lemasters   +4 more
openaire   +2 more sources

Redox regulation of cyclophilin A by glutathionylation

PROTEOMICS, 2006
AbstractUsing redox proteomics techniques to characterize the thiol status of proteins in human T lymphocytes, we identified cyclophilin A (CypA) as a specifically oxidized protein early after mitogen activation. CypA is an abundantly expressed cytosolic protein, target of the immunosuppressive drug cyclosporin A (CsA), for which a variety of functions
P. Ghezzi, S. Casagrande, T. Massignan, M. Basso, E. Bellacchio, L. Mollica, E. Biasini, R. Tonelli, I. Eberini, E. Gianazza, W. W. Dai, M. Fratelli, M. Salmona, B. Sherry, V. Bonetto   +14 more
openaire   +2 more sources

Structure of recombinant human cyclophilin J, a novel member of the cyclophilin family

Acta Crystallographica Section D Biological Crystallography, 2005
Cyclophilins (CyPs) are a large class of highly conserved ubiquitous peptidyl-prolyl cis-trans isomerases. CyPs have also been identified as being a specific receptor for the immunosuppressive drug cyclosporin A and are involved in a variety of biological functions.
Li Li, Huang, Xue Mei, Zhao, Chao Qun, Huang, Long, Yu, Zong Xiang, Xia   +4 more
openaire   +2 more sources

Role of Cyclophilin A in HIV Replication

Future Virology, 2006
A review. More than a decade has passed since the discovery that the peptidyl prolyl isomerase cyclophilin A (CypA) specifically binds to a proline-rich sequence in HIV-1 capsid (CA) and is thereby incorporated into viral particles. Since then, a variety of possible functions of CypA in the HIV-1 replication cycle have been intensively investigated ...
Votteler, J., Wray, V., Schubert, U.S.
openaire   +2 more sources